PeptiDream Inc. (TSE:4587) Filings
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Consolidated Financial Results for the Nine Months Ended September 30, 2026 [IFRS] | Nov 11, 2026 | Results | Tokyo Stock Exchange |
| PeptiDream Announces Initiation of Phase 1 Clinical Trial by MSD | Nov 5, 2026 | Operations update | Tokyo Stock Exchange |
| PeptiDream Announces Achievement of Development Milestone in Collaboration with MSD | Oct 7, 2026 | Operations update | Tokyo Stock Exchange |
| Consolidated Financial Results for the Six Months Ended June 30, 2026 [IFRS] | Aug 12, 2026 | Results | Tokyo Stock Exchange |
| Initiation of Phase 1 Clinical Trial by Novartis Marks Milestone for PeptiDream | Aug 11, 2026 | Other filings | Tokyo Stock Exchange |